Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble CD33 for treating myelodysplastic syndromes (MDS)

Soluble CD33 for treating myelodysplastic syndromes (MDS)

US Patent 11584787 · Granted Feb 21, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Towing device for vehicle and vehicle2025
Small molecule pyrin-domain targeted NLRP3 inflammasome inhibitors2025
Stapled H2 pyrin peptides2024
TLR9 ligand trap2024
TLR9 ligand trap2024
Remote control2023
System and method for low-latency content streaming2023
Pathways for treating patients2022
TLR9-binding chimeric antigen receptors2022
TLR9-binding chimeric antigen receptors2022
PD1 and PDL-1 expression during progression from myelodysplastic syndrome to acu2022
PD1 and PDL-1 expression during progression from myelodysplastic syndrome to acu2022